Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Predictors of doping intentions, susceptibility, and behaviour of elite athletes: a meta-analytic review.

Blank C, Kopp M, Niedermeier M, Schnitzer M, Schobersberger W.

Springerplus. 2016 Aug 11;5(1):1333. doi: 10.1186/s40064-016-3000-0. eCollection 2016. Review.

2.

A Comparison of the Cheater Detection and the Unrelated Question Models: A Randomized Response Survey on Physical and Cognitive Doping in Recreational Triathletes.

Schröter H, Studzinski B, Dietz P, Ulrich R, Striegel H, Simon P.

PLoS One. 2016 May 24;11(5):e0155765. doi: 10.1371/journal.pone.0155765. eCollection 2016.

3.

Doping knowledge, attitudes, and practices of Ugandan athletes': a cross-sectional study.

Muwonge H, Zavuga R, Kabenge PA.

Subst Abuse Treat Prev Policy. 2015 Sep 22;10:37. doi: 10.1186/s13011-015-0033-2.

4.

A questionnaire examining attitudes of collegiate athletes toward doping and pharmacists as information providers.

Malek S, Taylor J, Mansell K.

Can Pharm J (Ott). 2014 Nov;147(6):352-8. doi: 10.1177/1715163514552559.

5.

Attitudes and motivations of competitive cyclists regarding use of banned and legal performance enhancers.

Kisaalita NR, Robinson ME.

J Sports Sci Med. 2014 Jan 20;13(1):44-50. eCollection 2014 Jan.

6.

Dietary supplementation and doping-related factors in high-level sailing.

Rodek J, Sekulic D, Kondric M.

J Int Soc Sports Nutr. 2012 Dec 7;9(1):51. doi: 10.1186/1550-2783-9-51.

7.

The Olympics and harm reduction?

Kayser B, Broers B.

Harm Reduct J. 2012 Jul 13;9:33. doi: 10.1186/1477-7517-9-33.

8.

Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.

Kondric M, Sekulic D, Petroczi A, Ostojic L, Rodek J, Ostojic Z.

Subst Abuse Treat Prev Policy. 2011 Oct 11;6:27. doi: 10.1186/1747-597X-6-27.

9.

Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals.

Lucke JC, Bell SK, Partridge BJ, Hall WD.

EMBO Rep. 2011 Mar;12(3):197-201. doi: 10.1038/embor.2011.15. Epub 2011 Feb 11. No abstract available.

10.
11.

Virtue or pretense? Looking behind self-declared innocence in doping.

Petróczi A, Aidman EV, Hussain I, Deshmukh N, Nepusz T, Uvacsek M, Tóth M, Barker J, Naughton DP.

PLoS One. 2010 May 5;5(5):e10457. doi: 10.1371/journal.pone.0010457.

12.

Psychological drivers in doping: the life-cycle model of performance enhancement.

Petróczi A, Aidman E.

Subst Abuse Treat Prev Policy. 2008 Mar 10;3:7. doi: 10.1186/1747-597X-3-7.

Items per page

Supplemental Content

Write to the Help Desk